May 2013 - Page 11 of 23

FridayMay 17, 2013 9:24 am

Dynamics Research Corp. (DRCO) Announces Extension of Veterans Relationship Management Contract

Leading technology and management consulting company Dynamics Research Corp. (DRC) has announced that the Department of Veterans Affairs (VA), through the General Services Administration, has exercised the third year option of the Veterans Relationship Management Portfolio Monitoring and Coordination contract, extending the period of performance until May 10, 2014. The contract was awarded in May 2010 to High Performance Technologies, Inc., the company’s wholly owned subsidiary, and has a five-year performance period through May 2015 and a total contract value of $125.5 million. A multi-year initiative, Veterans Relationship Management restarts previously troubled programs with the end goal of providing veterans,…

FridayMay 17, 2013 9:22 am

Michael Matte Named CFO at Aspen Group, Inc. (ASPU)

Yesterday, Aspen Group, a nationally accredited online postsecondary education company, announced that Michael Matte has been named as the company’s Chief Financial Officer, effective immediately. Matte is taking over this role form David Garrity, Aspen’s former CFO; Garrity has been appointed EVP, Corporate Development, where he will head Aspen’s investor relations activities, M&A, and corporate partnerships. He will also be responsible for building Aspen’s corporate sales function, which is focused on institutional partnerships. Matte is joining Aspen Group having most recently been at MeetMe, Inc. as its CFO. He has over 20 years of experience as a CFO of both…

ThursdayMay 16, 2013 2:06 pm

DoMark International, Inc. (DOMK) Targets Smart Market

Mobile devices have become an indispensable personalized link to the outside world in ways that the developers of the original location-locked telephone never could have imagined. Increasingly we take our world with us, demanding answers and reach wherever we are, at any time of the day or night. It’s a tall order when you consider the volume and complexity of every person’s unique information flow. Over half of online activity now occurs through mobile devices, especially impressive when you consider the fact that Google alone, a focal point for online activity, gets over a billion visits every day. It translates…

ThursdayMay 16, 2013 1:32 pm

Industry Veteran Clive Raines Joins iTalk, Inc. (TALK) as Director of Australasia and Europe Operations

A global provider of advanced communications and mobile broadband services, iTalk has announced the appointment of Clive Raines as Director of Australasia and Europe Operations. With high voice quality and the lowest prices, iTalk Mobile is currently pushing the market for an industry alternative to traditional cellular coverage. Raines, whose resume includes extensive experience in better business practices in Australasia and Europe, will be welcomed to the team for his strong background in sales, marketing, strategic product development, and distribution. David F. Levy, Chief Executive Officer of iTalk, commented, "The Australasia and Europe region is poised for the same explosive…

ThursdayMay 16, 2013 12:25 pm

Rafarma Pharmaceuticals, Inc. (RAFA) Continues to Build Drug Pipeline

Rafarma Pharmaceuticals is one of Russia’s newest and most promising pharmaceutical companies. A company whose development and growth is being actively encouraged by the government, in a move to lessen Russian dependence upon western pharmaceutical companies for widely used pharmaceuticals, Rafarma is currently specializing in the production of generic antibiotics, but has a growing pipeline of other drugs, including proprietary products already approved. The company expects significant near-term results with its line of current and researched pharmaceuticals, including the following group of antibiotics. • Benzalconium Fluoride - Open randomized study of the efficacy and safety of the drug “benzalkonium fluoride,…

ThursdayMay 16, 2013 12:22 pm

Northwest Biotherapeutics, Inc. (NWBO) Begins Phase III Trial of DCVax-L for Brain Cancer

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products for the American and European markets to treat cancers more effectively than current treatments, while costing less, and without the toxicities associated chemotherapies. It is currently working on the DCVax-L personalized immune therapies for solid tumor cancers. The company announced today that its Phase III clinical trial with DCVax-L for brain cancer has begun at King's College Hospital in the U.K., a major European center for neuro-oncology. Other sites across Europe, including three more in the U.K. and nearly 20 in Germany, are in varying stages of preparations for…

ThursdayMay 16, 2013 9:06 am

Trio Resources, Inc. (TRII) Reports Q2 2013 Financial Results, Achieves First Revenues

Trio Resources, an exploration and small-scale processing company reported financial results for the second quarter ended March 31, 2013, marking the first revenues recorded since the company’s inception in May, 2012. The company also recapped its first-quarter achievements, including its five-year off-take agreement with United Commodity AG. "During the first quarter, we continued to distinguish ourselves from other junior mining companies by executing on our strategy to monetize our significant stockpiles of mineralized materials and securing a five year off-take agreement with United Commodity AG, one of the world's leading processors of precious metals," Duncan Reid, CEO of Trio Resources…

ThursdayMay 16, 2013 9:02 am

eMagin Corp. (EMAN) to Introduce World’s Brightest Full Color OLED Microdisplays

eMagin, a leader in OLED microdisplay technology, OLED microdisplay manufacturing know-how, and mobile display systems, announced yesterday that it has developed the world’s brightest family of super bright, energy efficient, and full color organic light emitting diode (OLED) microdisplays, called the Color OLED-XLS™. At 1000 nits of luminance, the Color OLED-XLS™ blows away the industry standard for brightness four times over. This new display is fully compatible with eMargin’s entire VGA, SVGA, SXGA, and WUXGA, and only requires half of the power of the company’s current color displays at the same brightness. This breakthrough display technology enables a much broader…

WednesdayMay 15, 2013 1:51 pm

VistaGen Therapeutics, Inc. (VSTA) Continues to Move Forward with Revolutionary Drug Testing Technology

VistaGen is a biotech company focused on using stem cell technology to generate new, safer variants (drug rescue variants) of once-promising small molecule drug candidates that were developed but ultimately discontinued by large pharmaceutical companies due to heart or liver toxicity issues. VistaGen aims to use their proprietary stem cell technology as a previously unavailable cost effective way to re-examine and ultimately “rescue” such lost drugs, thereby recovering the value from what is usually a substantial prior investment in research and development. The company recognizes the drug discovery and development crisis facing the U.S. pharmaceutical industry, where increasingly big investments…

WednesdayMay 15, 2013 1:39 pm

Golden Cross Resources, Inc. (CNSX:GOX), Blue Gold Tailing Technologies Ltd. Focus on Innovative Water Purification Solutions

Blue Gold Tailing Technologies is a water remediation company focusing on transforming contaminated waters into pure, safe, drinkable water. The company’s environmentally safe solutions address global water purification, restoration, and contamination issues, adhering to EPA guidelines as to what constitutes safe agricultural or drinkable water. Blue Gold then tailors these guidelines to acceptable standards in the jurisdiction in which the technology is used. This technology can also be used to recover heavy and precious metals from mine tailings. Privately held Blue Gold is currently undergoing acquisition by Golden Cross Resources via merger with Golden Cross’ Ontario subsidiary. The emerging company…

Site Search

Company Search

Month: May 2013